Oncomatryx Co-Authors Study on FAP-Targeted Bispecific Antibody Published in Science Advances

Science Advances Paper FAP CD3

The peer-reviewed study demonstrates how targeting the tumor microenvironment through a novel mechanism of action can trigger immune-driven antitumor effects ZAMUDIO (Bizkaia), 15th September 2026 – A study published in Science Advances, a journal of the American Association for the Advancement of Science (AAAS), describes how OMTX305, a bispecific antibody directed against the tumor microenvironment, … Leer más